Publications Publications Oncolytic immunotherapy: An emerging new modality for the treatment of cancer May 01, 2016 Infectious Enthusiasm Feb 29, 2016 Interview with Robert Coffin, inventor of T-VEC: the first oncolytic immunotherapy approved for the treatment of cancer. Feb 01, 2016 Print Page RSS Feeds RSS Feeds Email Alerts Email Alerts Contact IR Contact IR Search Search
Publications Oncolytic immunotherapy: An emerging new modality for the treatment of cancer May 01, 2016 Infectious Enthusiasm Feb 29, 2016 Interview with Robert Coffin, inventor of T-VEC: the first oncolytic immunotherapy approved for the treatment of cancer. Feb 01, 2016
Interview with Robert Coffin, inventor of T-VEC: the first oncolytic immunotherapy approved for the treatment of cancer. Feb 01, 2016
